Your search for supplemental oxygen returned 10 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Brian Park, PharmD remove
Older than 2 years remove
Home remove

Your search for supplemental oxygen returned 10 results

Sort Results:

Relevant Recent
Drugs in the Pipeline

Antiviral Merimepodib to Be Investigated in Phase 2 Trial for COVID-19

Following clearance of an Investigational New Drug Application by the Food and Drug Administration, ViralClear announced that a phase 2 study evaluating merimepodib oral solution for the treatment of coronavirus disease 2019 (COVID-19) will be initiated.

Mycamine Approved for Invasive Candidiasis in Younger Patients

The Food and Drug Administration has approved the supplemental New Drug Application (sNDA) for Mycamine (micafungin for injection; Astellas Pharma) for the treatment of candidemia, acute disseminated candidiasis, Candida peritonitis and abscesses without meningoencephalitis and/or ocular dissemination in pediatric patients aged <4 months.